| Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ... New England Journal of Medicine 379 (2), 111-121, 2018 | 933 | 2018 |
| Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes MP Goetz, JM Rae, VJ Suman, SL Safgren, MM Ames, DW Visscher, ... Journal of Clinical Oncology 23 (36), 9312-9318, 2005 | 893 | 2005 |
| MONARCH 3: abemaciclib as initial therapy for advanced breast cancer MP Goetz, M Toi, M Campone, J Sohn, S Paluch-Shimon, J Huober, ... Journal of Clinical Oncology 35 (32), 3638-3646, 2017 | 668 | 2017 |
| The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen MP Goetz, SK Knox, VJ Suman, JM Rae, SL Safgren, MM Ames, ... Breast cancer research and treatment 101 (1), 113-121, 2007 | 654 | 2007 |
| Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study MP Goetz, MR Callstrom, JW Charboneau, MA Farrell, TP Maus, TJ Welch, ... Journal of Clinical Oncology 22 (2), 300-306, 2004 | 588 | 2004 |
| Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen W Schroth, MP Goetz, U Hamann, PA Fasching, M Schmidt, S Winter, ... Jama 302 (13), 1429-1436, 2009 | 570 | 2009 |
| The Hsp90 chaperone complex as a novel target for cancer therapy MP Goetz, DO Toft, MM Ames, C Erlichman Annals of oncology 14 (8), 1169-1176, 2003 | 433 | 2003 |
| Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging R Katipamula, AC Degnim, T Hoskin, JC Boughey, C Loprinzi, CS Grant, ... Journal of Clinical Oncology 27 (25), 4082, 2009 | 383 | 2009 |
| Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer MP Goetz, D Toft, J Reid, M Ames, B Stensgard, S Safgren, AA Adjei, ... Journal of clinical oncology 23 (6), 1078-1087, 2005 | 351 | 2005 |
| Painful metastases involving bone: feasibility of percutaneous CT-and US-guided radio-frequency ablation MR Callstrom, JW Charboneau, MP Goetz, J Rubin, GY Wong, JA Sloan, ... Radiology 224 (1), 87-97, 2002 | 329 | 2002 |
| Invasive breast cancer version 1.2016, NCCN clinical practice guidelines in oncology WJ Gradishar, BO Anderson, R Balassanian, SL Blair, HJ Burstein, A Cyr, ... Journal of the National Comprehensive Cancer Network 14 (3), 324-354, 2016 | 327 | 2016 |
| NCCN guidelines insights: breast cancer, version 1.2017 WJ Gradishar, BO Anderson, R Balassanian, SL Blair, HJ Burstein, A Cyr, ... Journal of the National Comprehensive Cancer Network 15 (4), 433-451, 2017 | 303 | 2017 |
| Use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: American Society of Clinical Oncology Clinical Practice Guideline C Van Poznak, MR Somerfield, RC Bast, M Cristofanilli, MP Goetz, ... Journal of clinical oncology 33 (24), 2695, 2015 | 283 | 2015 |
| Tailoring adjuvant endocrine therapy for premenopausal breast cancer PA Francis, O Pagani, GF Fleming, BA Walley, M Colleoni, I Láng, ... New England Journal of Medicine 379 (2), 122-137, 2018 | 249 | 2018 |
| The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor α for degradation in breast cancer cells X Wu, JR Hawse, M Subramaniam, MP Goetz, JN Ingle, TC Spelsberg Cancer research 69 (5), 1722-1727, 2009 | 236 | 2009 |
| Painful Metastases Involving Bone: Percutaneous Image-guided Cryoablation—Prospective Trial Interim Analysis1 MR Callstrom, TD Atwell, JW Charboneau, MA Farrell, MP Goetz, J Rubin, ... Radiology 241 (2), 572-580, 2006 | 233 | 2006 |
| Percutaneous image‐guided cryoablation of painful metastases involving bone: Multicenter trial MR Callstrom, DE Dupuy, SB Solomon, RA Beres, PJ Littrup, KW Davis, ... Cancer 119 (5), 1033-1041, 2013 | 223 | 2013 |
| Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response MP Goetz, A Kamal, MM Ames Clinical Pharmacology & Therapeutics 83 (1), 160-166, 2008 | 220 | 2008 |
| Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2 … MF Rimawi, IA Mayer, A Forero, R Nanda, MP Goetz, AA Rodriguez, ... Journal of clinical oncology 31 (14), 1726, 2013 | 219 | 2013 |
| Breast cancer, version 4.2017, NCCN clinical practice guidelines in oncology WJ Gradishar, BO Anderson, R Balassanian, SL Blair, HJ Burstein, A Cyr, ... Journal of the National Comprehensive Cancer Network 16 (3), 310-320, 2018 | 218 | 2018 |
Krishna Rani KalariAssociate Professor, Mayo ClinicVerified email at mayo.edu
